ArticleOphthalmology science

A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium.

Scott M Whitcup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.